UBS Cuts Sabra Healthcare REIT Price Target to $20 From $21
UBS maintained its Neutral rating on Sabra Healthcare REIT while lowering its price target to $20 per share from $21.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.